Page last updated: 2024-10-21

vanilmandelic acid and Respiratory Distress Syndrome, Newborn

vanilmandelic acid has been researched along with Respiratory Distress Syndrome, Newborn in 2 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Respiratory Distress Syndrome, Newborn: A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hakulinen, A1
Pribylová, H1
Herzmann, J1

Other Studies

2 other studies available for vanilmandelic acid and Respiratory Distress Syndrome, Newborn

ArticleYear
Urinary excretion of vanilmandelic acid of children in normal and certain pathological conditions.
    Acta paediatrica Scandinavica. Supplement, 1971, Volume: 212

    Topics: Adolescent; Age Factors; Asthma; Body Temperature; Child; Child, Preschool; Diabetes Mellitus, Type

1971
[Excretion of various steroids, vanilmandelic acid and lactic acid in newborn infants of diabetic mothers].
    Archiv fur Kinderheilkunde, 1970, Volume: 180, Issue:3

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Blood Glucose; Female; Humans; Hyperglycemia; Infant, Ne

1970